Groowe Groowe / Newsroom / JNJ
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

JNJ News

Johnson & Johnson

Jcovden (Johnson & Johnson) Market Research Report 2026: Epidemiology, Pipeline Analysis, Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

globenewswire.com
JNJ

Jcovden (Johnson & Johnson) Market Research Report 2026: Epidemiology, Pipeline Analysis, Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

globenewswire.com
JNJ

European Commission approves AKEEGA® (niraparib and abiraterone acetate dual action tablet) for the treatment of patients with BRCA1/2-mutated metastatic hormone-sensitive prostate cancer (mHSPC)

globenewswire.com
JNJ GSK

Crewstone International Concludes Asean Roadshow for Solyco SPV II, Advancing Cross-Border Capital into High-Growth U.S. & U.K. Private Companies

accessnewswire.com
AIG AMGN XOM UPS JNJ

China sets priorities for 2026 and beyond at the Two Sessions

prnewswire.com
WMT COST MCD SBUX AMZN BABA JD NKE GM F TSLA NVDA INTC MSFT GOOGL AAPL PFE JNJ MRK

Global Times: A target of seeking progress while maintaining stability, being proactive and pragmatic

prnewswire.com
LUV XPEV LI NIO PLUG SEDG ENPH DQ JKS BE FCEL RUN FSLR BABA JD PDD BYDDY TSLA GM F RIVN LCID NVDA AMD INTC MU AMAT LRCX KLAC ASML SMCI MSFT GOOGL AMZN IBM ORCL CRM ADBE PYPL COIN UPST SOFI AXP V MA GS JPM MS BAC WFC CMCSA VZ T NFLX DIS CMG MCD SBUX YUM PEP KO PG JNJ PFE MRK BMY LLY ABBV GILD AMGN BIIB REGN VRTX MRNA BNTX AZN NVO SNY XOM CVX SHEL BZUN VIPS QCOM MRVL NXPI ON ADI MCHP AVGO QGEN ILMN EXAS MDLZ KDP GIS KHC CL EL NKE UA LULU CPRI PVH M TJX ROST BBY HD LOW COST WMT TGT KR LVS MGM WYNN CCL RCL NCLH DAL UAL AAL BA GD LMT RTX GE HON CAT DE MMM DOW DD ECL IFF ADM CF MOS NTR BHP RIO VALE AA FCX STLD NUE CFG KEY USB PNC BBT STI BBVA HSBC SCHW RJF SYF CINF

Aerogel Market to Hit USD 1.59 Billion by 2031 as Energy, Construction, and Mobility Sectors Increase Adoption of Advanced Insulation Materials, Says Mordor Intelligence

globenewswire.com
DD MMM JNJ

Johnson & Johnson Announces U.S. FDA Approval of TECVAYLI® plus DARZALEX FASPRO® for Relapsed/Refractory Multiple Myeloma, Offering a Potential New Standard of Care as Early as Second Line

prnewswire.com
JNJ

Anxiety Treatment Boom: GAD Therapies Poised for Multi-Billion Dollar Expansion

prnewswire.com
HELP AIFF JNJ ACHC BWAY

Advita Ortho Announces Executive Leadership Appointments

prnewswire.com
DHR JNJ SNN